CAITLIN NORMOYLE: Open Payments
NPI 1588403265 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,769 in 75 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $26 · 2025 $1,769
Food & beverage: $1,769
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $364 |
| Novo Nordisk Inc | 13 | $353 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $189 |
| Amgen Inc. | 4 | $102 |
| Janssen Pharmaceuticals, Inc | 3 | $95 |
| Ardelyx, Inc. | 4 | $89 |
| Lilly USA, LLC | 4 | $88 |
| PFIZER INC. | 4 | $87 |
| Exact Sciences Corporation | 3 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
Products named: Wegovy, UBRELVY, JARDIANCE, QULIPTA, Ozempic, SPRAVATO, IBSRELA, KISUNLA.
Industry payments across CT — which companies pay providers there.
